Literature DB >> 25005651

Effect of postoperative antibiotic administration on postoperative infection following cholecystectomy for acute calculous cholecystitis: a randomized clinical trial.

Jean Marc Regimbeau1, David Fuks2, Karine Pautrat3, Francois Mauvais4, Vincent Haccart5, Simon Msika6, Muriel Mathonnet7, Michel Scotté8, Jean Christophe Paquet9, Corinne Vons10, Igor Sielezneff11, Bertrand Millat12, Laurence Chiche13, Hervé Dupont14, Pierre Duhaut15, Cyril Cossé2, Momar Diouf16, Marc Pocard3.   

Abstract

IMPORTANCE: Ninety percent of cases of acute calculous cholecystitis are of mild (grade I) or moderate (grade II) severity. Although the preoperative and intraoperative antibiotic management of acute calculous cholecystitis has been standardized, few data exist on the utility of postoperative antibiotic treatment.
OBJECTIVE: To determine the effect of postoperative amoxicillin plus clavulanic acid on infection rates after cholecystectomy. DESIGN, SETTING, AND PATIENTS: A total of 414 patients treated at 17 medical centers for grade I or II acute calculous cholecystitis and who received 2 g of amoxicillin plus clavulanic acid 3 times a day while in the hospital before and once at the time of surgery were randomized after surgery to an open-label, noninferiority, randomized clinical trial between May 2010 and August 2012.
INTERVENTIONS: After surgery, no antibiotics or continue with the preoperative antibiotic regimen 3 times daily for 5 days. MAIN OUTCOMES AND MEASURES: The proportion of postoperative surgical site or distant infections recorded before or at the 4-week follow-up visit.
RESULTS: An imputed intention-to-treat analysis of 414 patients showed that the postoperative infection rates were 17% (35 of 207) in the nontreatment group and 15% (31 of 207) in the antibiotic group (absolute difference, 1.93%; 95% CI, -8.98% to 5.12%). In the per-protocol analysis, which involved 338 patients, the corresponding rates were both 13% (absolute difference, 0.3%; 95% CI, -5.0% to 6.3%). Based on a noninferiority margin of 11%, the lack of postoperative antibiotic treatment was not associated with worse outcomes than antibiotic treatment. Bile cultures showed that 60.9% were pathogen free. Both groups had similar Clavien complication severity outcomes: 195 patients (94.2%) in the nontreatment group had a score of 0 to I and 2 patients (0.97%) had a score of III to V, and 182 patients (87.8%) in the antibiotic group had a score of 0 to I and 4 patients (1.93%) had a score of III to V. CONCLUSIONS AND RELEVANCE: Among patients with mild or moderate calculous cholecystitis who received preoperative and intraoperative antibiotics, lack of postoperative treatment with amoxicillin plus clavulanic acid did not result in a greater incidence of postoperative infections. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01015417.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25005651     DOI: 10.1001/jama.2014.7586

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  29 in total

Review 1.  Surgical management of acute cholecystitis.

Authors:  Rahul S Koti; Christopher J Davidson; Brian R Davidson
Journal:  Langenbecks Arch Surg       Date:  2015-05-14       Impact factor: 3.445

2.  The Value of Abdominal Drainage After Laparoscopic Cholecystectomy for Mild or Moderate Acute Calculous Cholecystitis: A Post Hoc Analysis of a Randomized Clinical Trial.

Authors:  Flavien Prevot; David Fuks; Cyril Cosse; Karine Pautrat; Simon Msika; Muriel Mathonnet; Haitham Khalil; François Mauvais; Jean-Marc Regimbeau
Journal:  World J Surg       Date:  2016-11       Impact factor: 3.352

Review 3.  A Roadmap for Reducing Cardiac Device Infections: a Review of Epidemiology, Pathogenesis, and Actionable Risk Factors to Guide the Development of an Infection Prevention Program for the Electrophysiology Laboratory.

Authors:  Westyn Branch-Elliman
Journal:  Curr Infect Dis Rep       Date:  2017-08-16       Impact factor: 3.725

4.  Antibiotic administration after cholecystectomy for acute mild-moderate cholecystitis: a PRISMA-compliant meta-analysis.

Authors:  Davide La Regina; Matteo Di Giuseppe; Stefano Cafarotti; Andrea Saporito; Marcello Ceppi; Francesco Mongelli; Florian Bihl; Ruben Carlo Balzarotti Canger; Antonjacopo Ferrario di Tor Vajana
Journal:  Surg Endosc       Date:  2018-10-16       Impact factor: 4.584

5.  The optimal treatment of patients with mild and moderate acute cholecystitis: time for a revision of the Tokyo Guidelines.

Authors:  Charlotte S Loozen; Maaike M Blessing; Bert van Ramshorst; Hjalmar C van Santvoort; Djamila Boerma
Journal:  Surg Endosc       Date:  2017-01-26       Impact factor: 4.584

6.  Antibiotics May be Safely Discontinued Within One Week of Percutaneous Cholecystostomy.

Authors:  Tyler J Loftus; Scott C Brakenridge; Camille G Dessaigne; George A Sarosi; William J Zingarelli; Frederick A Moore; Janeen R Jordan; Chasen A Croft; R Stephen Smith; Phillip A Efron; Alicia M Mohr
Journal:  World J Surg       Date:  2017-05       Impact factor: 3.352

7.  Clinical implication of bactibilia in moderate to severe acute cholecystitis undergone cholecystostomy following cholecystectomy.

Authors:  Je Ho Yoon; Kwang Yeol Paik; Hoo Young Chung; Ji Seon Oh
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

8.  Grading operative findings at laparoscopic cholecystectomy- a new scoring system.

Authors:  Michael Sugrue; Shaheel M Sahebally; Luca Ansaloni; Martin D Zielinski
Journal:  World J Emerg Surg       Date:  2015-03-08       Impact factor: 5.469

Review 9.  Reduction of risk of infection during elective laparoscopic cholecystectomy using prophylactic antibiotics: a systematic review and meta-analysis.

Authors:  Jia Yang; Shiyi Gong; Tingting Lu; Hongwei Tian; Wutang Jing; Yang Liu; Moubo Si; Caiwen Han; Kehu Yang; Tiankang Guo
Journal:  Surg Endosc       Date:  2021-08-09       Impact factor: 4.584

10.  Protocol for extended antibiotic therapy after laparoscopic cholecystectomy for acute calculous cholecystitis (Cholecystectomy Antibiotic Randomised Trial, CHART).

Authors:  Pablo Pellegrini; Juan Pablo Campana; Agustín Dietrich; Jeremías Goransky; Juan Glinka; Diego Giunta; Laura Barcan; Fernando Alvarez; Oscar Mazza; Rodrigo Sánchez Claria; Martin Palavecino; Guillermo Arbues; Victoria Ardiles; Eduardo de Santibañes; Juan Pekolj; Martin de Santibañes
Journal:  BMJ Open       Date:  2015-11-18       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.